Engineers at the University of Pennsylvania have modified lipid nanoparticles to not only cross the blood-brain barrier but also to target specific types of cells, including neurons. The researchers showed how short strings of amino acids can serve as precise targeting molecules, enabling the lipid nanoparticles to deliver mRNA specifically to the endothelial cells that line the blood vessels of the brain, as well as neurons. This breakthrough marks a significant step toward potential next-generation treatments for neurological diseases like Alzheimer's and Parkinson's.
An official website of the United States government.